603127 (603127) News
Follow 603127 (603127) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Joinn Laboratories China Says From Apr 20 To Sept 23, Unit Subscribed For Citic Securities Financial Products
Joinn Laboratories China Co Ltd SSE:603127
GEOPOLITICS | Sep 23, 2026, 10:30 AM UTC
L
Joinn Laboratories China does not recommend interim dividend payment
Joinn Laboratories China does not recommend payment of any interim dividend.
GEOPOLITICS | Aug 28, 2026, 10:35 AM UTC
M
Joinn Laboratories H1 profit jumps 1,127% on drug demand
Joinn Laboratories reported H1 profit up 1,127% amid strong drug demand, per TradingView News.
GEOPOLITICS | Aug 28, 2026, 09:54 AM UTC
M
Joinn Laboratories China H1 net profit up 1,126.8% Y/Y
Joinn Laboratories China reported H1 net profit up 1,126.8% year-over-year.
GEOPOLITICS | Aug 28, 2026, 08:57 AM UTC